does anyone have an opinion on $ARGX (+0.96%) and $AME (+1.27%) ? look like brutally strong companies
ArgenxNL0010832176ARGXARGX
Argenx
NL0010832176
ARGX
ARGX
Financials
Market Cap
$31.74B5Y beta
0.62EPS (TTM)
-$3.494Free Float
59.72MRevenue (TTM)
$1.62BEBITDA (TTM)
-$353.68MPricing
52W span
$297.58$554.70
Analyst Ratings
The price target is $505.16 and the stock is covered by 20 analysts.
Buy
14
Hold
5
Sell
1
Information
1148Biotechnology & DrugsHealth Care
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.
Identifier
ISIN
NL0010832176
Primary Ticker
ARGX